Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, if any, might work best.

Imunon Inc. soared by 179% on the heels of phase II Ovation 2 data showing that its IMNN-001 immunotherapy led to a 13-month increase in overall survival among women with ovarian cancer. Patients in ...

This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...

Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools.

Former president Joe Biden has been diagnosed with prostate cancer, his office announced on Sunday. The 82-year-old has what ...

To address this challenge, CTMC has established a patient material bank, enabling early-stage process development with ...

Ovarian cancer, often diagnosed late due to subtle symptoms, sees significantly improved survival rates with early detection.

A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding ...

New research led by scientists in Ireland has uncovered how a fat-rich fluid found in the abdomen of ovarian cancer patients ...

It took almost a decade for Aliza Lynch to confirm she had endometriosis despite living with crippling pain that was so bad ...

On World Ovarian Cancer Day ... Benign ovarian tumours and germ cell tumours that present early in life are potentially curable with normal life expectancy. Epithelial ovarian tumours need ...